Nada Jabado

University of California, Riverside — United States

Medicine · Health Sciences

106h-index47.3kcitations792works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(428), Neuroblastoma Research and Treatments(131), Epigenetics and DNA Methylation(79), Chromatin Remodeling and Cancer(70), Cancer, Hypoxia, and Metabolism(52)

Publications777 total

Supplementary Table 6 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
2025Open Access
Supplementary Table 4 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
2025Open Access
Supplementary Tables 1-3, 7-9 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
2025Open Access
Supplementary Table 5 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
2025Open Access
Supplementary Figures 1-27 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
2025Open Access
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Cancer Cell·2025· 3 citedOpen Access
Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy
Neuro-Oncology Advances·2025Open Access
A Systematic Study of Molecular Diagnosis, Treatment and Prognosis in Infant-Type Hemispheric Glioma): An Individual Patient Data Meta-analysis of 164 patients
Universität Zürich, ZORA·2025Open Access
EXTH-69. CD155 regulates tumor growth and immune evasion in diffuse midline glioma
Neuro-Oncology·2025Open Access
Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors
The EMBO Journal·2025Open Access
Bevacizumab in Pediatric Neuro-Oncology
Current Oncology·2025Open Access
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
Nature Communications·2025Open Access
Unveiling the temporal impact: Exploring dynamic changes in the paediatric solid tumour immune microenvironment through time
2025Open Access
Single-workflow Nanopore whole genome sequencing with adaptive sampling for accelerated and comprehensive pediatric cancer profiling
2025Open Access
JS07.6.A AGE-APPROPRIATE MODELS OF PAEDIATRIC BRAIN TUMOURS REVEAL THE INFLUENCE OF AGE ON TUMOUR-IMMUNE INTERACTION.
Neuro-Oncology·2025Open Access
Abstract A014: Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology
Cancer Research·2025
Abstract B019: O-mannosylation represents a therapeutic opportunity in BRAF fusion protein oncogenesis
Cancer Research·2025
Abstract A032: Molecular insights into KIAA1549::BRAF fusion proteins: Implications for targeted therapy in pediatric low-grade gliomas
Cancer Research·2025
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma
Nature Immunology·2025· 1 cited
CD155 regulates tumor growth and immune evasion in diffuse midline glioma
2025Open Access
page 1 of 39Next →

Frequent Co-authors

David Jones(26), Stefan M. Pfister(24), Andrey Korshunov(21), Marcel Kool(20), Michael D. Taylor(18), Jacek Majewski(17), Paul A. Northcott(16), Dominik Sturm(15), Peter Lichter(15), Cynthia Hawkins(15), Andreas von Deimling(13), Olaf Witt(12), Uri Tabori(12), Éric Bouffet(12), Jeremy Schwartzentruber(11), Adam M. Fontebasso(11), Marina Ryzhova(11), Till Milde(11), Damien Faury(11), Marc Remke(11)